-Raymond F Schinazi Researcher Activity Profile

Research Author Detailed Information 

Raymond F Schinazi Publication Rate By Year

Raymond F Schinazi has published 5 paper(s) in 2006, 10 paper(s) in 2007, 2 paper(s) in 2008, for a total of 17 research publications in total.

Raymond F Rf Schinazi Author Information

LAST NAME: schinazi

FIRST NAME: Raymond F

INITIALS: rf

AFFILIATION:

Papers

Raymond F Schinazi's Publication Record

1. Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Year Published: 2006
Pharmasset Inc, Princeton, NJ, USA.
2. Synthesis of neplanocin F analogues as potential antiviral agents. Year Published: 2006
The University of Georgia College of Pharmacy, Athens, GA 30602, USA.
3. Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity. Year Published: 2006
Department of Pharmacognosy and the National Center for Natural Products Research (NCNPR), University of Mississippi School of Pharmacy, MS 38677, USA.
4. Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents. Year Published: 2006
Pharmasset, Inc., Princeton, New Jersey 08540, USA. kwon.chun@pharmasset.com
5. Enantioselective synthesis and antiviral activity of purine and pyrimidine cyclopentenyl C-nucleosides. Year Published: 2006
The University of Georgia College of Pharmacy, Athens, GA 30602, USA.
6. PAMAM dendrimers and branched polyethyleneglycol (nanoparticles) prodrugs of (-)-beta-D-(2R, 4R)-dioxolane-thymine (DOT) and their anti-HIV activity. Year Published: 2007
The University of Georgia College of Pharmacy, Athens, GA, USA.
7. Interaction of 2'-deoxyguanosine triphosphate analogue inhibitors of HIV reverse transcriptase with human mitochondrial DNA polymerase gamma. Year Published: 2007
Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
8. Synthesis and evaluation of 2'-substituted cyclobutyl nucleosides and nucleotides as potential anti-HIV agents. Year Published: 2007
Department of Chemistry, Emory University, Atlanta, GA 30322, USA.
9. Synthesis and anti-HIV activity of (-)-beta-D-(2R,4R)-1,3-dioxolane-2,6-diamino purine (DAPD) (amdoxovir) and (-)-beta-D-(2R,4R)-1,3-dioxolane guanosine (DXG) prodrugs. Year Published: 2007
The University of Georgia College of Pharmacy, Athens, GA 30602, United States.
10. Pharmacokinetics of the antiviral agent beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine in rhesus monkeys. Year Published: 2007
Veterans Affairs Medical Center, Medical Research 151H, Decatur, GA 30033, USA.
11. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Year Published: 2007
Department of Pediatrics and Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
12. Pharmacokinetics of the anti-human immunodeficiency virus agent 1-(beta-D-dioxolane)thymine in rhesus monkeys. Year Published: 2007
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
13. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection. Year Published: 2007
Gastrointestinal Unit, Department of Clinical Sciences, College of Veterinary Medicine, Room C-2005 VMC, Cornell University, Ithaca, NY 14853, USA. sm119@cornell.edu
14. Development of a novel mouse model to evaluate drug candidates against hepatitis B virus. Year Published: 2007
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA. mfeitelson1@yahoo.com
15. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection. Year Published: 2007
Gastrointestinal Unit, Department of Clinical Sciences, College of Veterinary Medicine, Room C-2005 VMC, Cornell University, Ithaca, NY 14853, USA. sm119@cornell.edu
16. Antiviral and anticancer optimization studies of the DNA-binding marine natural product aaptamine. Year Published: 2008
Department of Pharmacognosy, School of Pharmacy and The University of Mississippi, University, MS 38677, USA.
17. Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase. Year Published: 2008
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520-8066, USA.